| dc.creator | Chatzis D.G., Magounaki K., Pantazopoulos I., Bhaskar S.M.M. | en |
| dc.date.accessioned | 2023-01-31T07:44:25Z | |
| dc.date.available | 2023-01-31T07:44:25Z | |
| dc.date.issued | 2022 | |
| dc.identifier | 10.12998/wjcc.v10.i27.9602 | |
| dc.identifier.issn | 23078960 | |
| dc.identifier.uri | http://hdl.handle.net/11615/72697 | |
| dc.description.abstract | The current coronavirus disease 2019 (COVID-19) pandemic has had devastating impact on populations around the world. The high mortality rates in patients with COVID-19 has been attributed to the influence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), its causative viral agent, on several physiological systems in human body, including the respiratory, cardiovascular, and neurological systems. There is emerging evidence on propensity of this virus to attack cardiovascular system. However, various pathophysiological mechanisms by which SARS-CoV-2 interacts with cardiovascular system and leads to high morbidity and mortality, including cardiovascular complications, are poorly understood. This mini review aims to provide an update on the current knowledge and perspectives on areas of future research © The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved | en |
| dc.language.iso | en | en |
| dc.source | World Journal of Clinical Cases | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85138580615&doi=10.12998%2fwjcc.v10.i27.9602&partnerID=40&md5=9644bb52d8cb5b507232d5e871bcacff | |
| dc.subject | angiotensin converting enzyme 2 | en |
| dc.subject | acute coronary syndrome | en |
| dc.subject | Article | en |
| dc.subject | cardiovascular disease | en |
| dc.subject | cardiovascular magnetic resonance | en |
| dc.subject | cardiovascular system | en |
| dc.subject | coronavirus disease 2019 | en |
| dc.subject | heart arrest | en |
| dc.subject | heart failure | en |
| dc.subject | heart muscle injury | en |
| dc.subject | human | en |
| dc.subject | hypercoagulability | en |
| dc.subject | immunology | en |
| dc.subject | morbidity | en |
| dc.subject | mortality | en |
| dc.subject | myocarditis | en |
| dc.subject | nervous system | en |
| dc.subject | pathophysiology | en |
| dc.subject | physiology | en |
| dc.subject | respiratory system | en |
| dc.subject | Severe acute respiratory syndrome coronavirus 2 | en |
| dc.subject | takotsubo cardiomyopathy | en |
| dc.subject | venous thromboembolism | en |
| dc.subject | Baishideng Publishing Group Inc | en |
| dc.title | COVID-19 and the cardiovascular system-current knowledge and future perspectives | en |
| dc.type | journalArticle | en |
